Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antioxidant Therapy in RYR1-Related Congenital Myopathy
NCT02362425Phase 2Completed
- Sponsor
- National Institute of Nursing Research
- Start
- Feb 2015
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in RYR1-related myopathy (RYR1-RM), sponsored by National Institute of Nursing Research. Started Feb 2015; status: completed.
02
Drugs
acetylcysteine
03
Conditions
RYR1-related myopathy (RYR1-RM)
Beyond the preview
Go deeper on NCT02362425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02362425.